Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Verrijckt
Ann
A
Department of Pediatrics, Section of Intensive Care Medicine, ainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada. annverrijckt@yahoo.com
Proulx
François
F
Morneau
Sylvain
S
Vobecky
Suzanne
S
D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000379:methods; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects* / Q000379:methods; D015942:Factor VIIa / Q000627:therapeutic use*; D017809:Fatal Outcome; D006489:Hemostatic Techniques; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D019106:Postoperative Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D014188:Transposition of Great Vessels / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
D015942:Factor VIIa